Group name
None
Groups remarks
Group 1 consisted of patients who received no additional treatment
T2a
1 (2.2%)
T2c
15 (33.3%)
T3a
17 (60.0%)
>T3b
2 (4.4%)
T4
0
GS 2-6
GS 7
34 (75.6%)
GS 8-10
10 (22.2%)